Iron and volume in the deep gray matter: Association with cognitive impairment in multiple sclerosis

American Journal of Neuroradiology

Volumn 36, Issue 1, 2015, Pages 57-62

  Modica, C M ^a   Zivadinov, R ^a,b   Dwyer, M G ^a   Bergsland, N ^a,c   Weeks, A R ^a   Benedict, Ralph H B ^a,b  

^a UNIVERSITY AT BUFFALO   (United States)

^b UNIVERSITY AT BUFFALO   (United States)

^c IRCCS FONDAZIONE DON CARLO GNOCCHI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BETA1A INTERFERON; GLATIRAMER; IMMUNOGLOBULIN; INTERFERON BETA SERINE; IRON; MITOXANTRONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NATALIZUMAB; STEROID;

ADULT; ARTICLE; BRAIN SIZE; CAUDATE NUCLEUS; COGNITIVE DEFECT; CONTROLLED STUDY; DISEASE DURATION; FEMALE; GLOBUS PALLIDUS; GRAY MATTER; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PULVINAR; PUTAMEN; THALAMUS; ATROPHY; CHEMISTRY; COGNITION DISORDERS; COMPLICATION; MIDDLE AGED; PATHOLOGY; PROCEDURES;

ADULT; ATROPHY; COGNITION DISORDERS; FEMALE; GRAY MATTER; HUMANS; IRON; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS;

EID: 84920972936     PISSN: 01956108     EISSN: 1936959X     Source Type: Journal    
DOI: 10.3174/ajnr.A3998     Document Type: Article

References (39)

1. Craelius W, Migdal MW, Luessenhop CP, et al. Iron deposits surrounding multiple sclerosis plaques. Arch Pathol Lab Med 1982;106:397-99
2. LeVine SM, Lynch SG, Ou CN, et al. Ferritin, transferrin and iron concentrations in the cerebrospinal fluid of multiple sclerosis patients. Brain Res 1999;821:511-15
3. Williams R, Buchheit CL, Berman NE, et al. Pathogenic implications of iron accumulation in multiple sclerosis. J Neurochem 2012;120:7-25
4. Haacke EM, Xu Y, Cheng YC, et al. Susceptibility weighted imaging (SWI). Magn Reson Med 2004;52:612-18
5. Zivadinov R, Heininen-Brown M, Schirda CV, et al. Abnormal subcortical deep-gray matter susceptibility-weighted imaging filtered phase measurements in patients with multiple sclerosis: A case-control study. Neuroimage 2012;59:331-39
6. Hagemeier J, Weinstock-Guttman B, Bergsland N, et al. Iron deposition on SWI-filtered phase in the subcortical deep gray matter of patients with clinically isolated syndrome may precede structurespecific atrophy. AJNR Am J Neuroradiol 2012;33:1596-601
7. Hagemeier J, Yeh EA, Brown MH, et al. Iron content of the pulvinar nucleus of the thalamus is increased in adolescent multiple sclerosis. Mult Scler 2013;19:567-76
8. Al-Radaideh AM, Wharton SJ, Lim SY, et al. Increased iron accumulation occurs in the earliest stages of demyelinating disease: An ultra- high field susceptibility mapping study in clinically isolated syndrome. Mult Scler 2013;19:896-903
9. Zivadinov R, Sepcic J, Nasuelli D, et al. A longitudinal study of brain atrophy and cognitive disturbances in the early phase of relapsingremitting multiple sclerosis. J Neurol Neurosurg Psychiatry 2001; 70:773-80
10. Benedict RH, Weinstock-Guttman B, Fishman I, et al. Prediction of neuropsychological impairment in multiple sclerosis: Comparison of conventional magnetic resonance imaging measures of atrophy and lesion burden. Arch Neurol 2004;61:226-30
11. Fisher E, Lee JC, Nakamura K, et al. Gray matter atrophy in multiple sclerosis: A longitudinal study. Ann Neurol 2008;64:255-65
12. Benedict RH, Schwartz CE, Duberstein P, et al. Influence of personality on the relationship between gray matter volume and neuropsychiatric symptoms in multiple sclerosis. Psychosom Med 2013; 75:253-61
13. Batista S, Zivadinov R, Hoogs M, et al. Basal ganglia, thalamus and neocortical atrophy predicting slowed cognitive processing in multiple sclerosis. J Neurol 2012;259:139-46
14. Schoonheim MM, Popescu V, Rueda Lopes FC, et al. Subcortical atrophy and cognition: Sex effects in multiple sclerosis. Neurology 2012;79:1754-61
15. Bergsland N, Horakova D, Dwyer MG, et al. Subcortical and cortical gray matter atrophy in a large sample of patients with clinically isolated syndrome and early relapsing-remitting multiple sclerosis. AJNR Am J Neuroradiol 2012;33:1573-78
16. Aubert-Broche B, Fonov V, Ghassemi R, et al. Regional brain atrophy in children with multiple sclerosis. NeuroImage 2011;58:409-15
17. Calabrese M, Rinaldi F, Grossi P, et al. Basal ganglia and frontal/ parietal cortical atrophy is associated with fatigue in relapsing-remitting multiple sclerosis. Mult Scler 2010;16:1220-28
18. Hagemeier J, Weinstock-Guttman B, Heininen-Brown M, et al. Gray matter SWI-filtered phase and atrophy are linked to disability in MS. Front Biosci (Elite Ed) 2013;5:525-32
19. Polman CH, Reingold SC, Edan G, et al. Diagnostic criteria for multiple sclerosis: 2005 revisions to the "McDonald Criteria." Ann Neruol 2005;58:840-46
20. Zivadinov R, Rudick RA, De Masi R, et al. Effects of IV methylprednisolone on brain atrophy in relapsing-remitting MS. Neurology 2001;57:1239-47
21. Patenaude B, Smith SM, Kennedy DN, et al. A Bayesian model of shape and appearance for subcortical brain segmentation. Neuroimage 2011;56:907-22
22. Hagemeier J, Dwyer MG, Bergsland N, et al. Effect of age on MRI phase behavior in the subcortical deep gray matter of healthy individuals. AJNR Am J Neuroradiol 2013;34:2144-51
23. Benedict RH, Fischer JS, Archibald CJ, et al. Minimal neuropsychological assessment of MS patients: A consensus approach. Clin Neuropsychol 2002;16:381-97
24. Smith A. Symbol Digit Modality Test Manual. Los Angeles: Western Psychological Services; 1982
25. Gronwall DM. Paced auditory serial-addition task: A measure of recovery from concussion. Percept Mot Skills 1977;44:367-73
26. Delis DC, Kaplan E, Kramer JH. Delis-Kaplan Executive Function System (D-KEFS): New York: Psychological Corporation; 2001
27. Delis DC, Kramer JH, Kaplan E, et al. California Verbal Learning Test. 2nd ed. San Antonio: Psychological Corporation; 2000
28. Benedict R. Brief Visuospatial Memory Test-Revised. Odessa, Florida: Psychological Assessment Resources; 1997
29. Benedict RH, Cookfair D, Gavett R, et al. Validity of the minimal assessment of cognitive function in multiple sclerosis (MACFIMS). J Int Neuropsychol Soc 2006;12:549-58
30. Benedict RH, Bruce JM, Dwyer MG, et al. Neocortical atrophy, third ventricular width, and cognitive dysfunction in multiple sclerosis. Arch Neurol 2006;63:1301-06
31. Khalil M, Langkammer C, Ropele S, et al. Determinants of brain iron in multiple sclerosis: A quantitative 3T MRI study. Neurology 2011;77:1691-97
32. Brass SD, Benedict RH, Weinstock-Guttman B, et al. Cognitive impairment is associated with subcortical magnetic resonance imaging grey matter T2 hypointensity in multiple sclerosis. Mult Scler 2006;12:437-44
33. Haacke EM, Miao Y, Liu M, et al. Correlation of putative iron content as represented by changes in R2.∗ and phase with age in deep gray matter of healthy adults. J Magn Reson Imaging 2010;32:561-76
34. Schenker C, Meier D, Wichmann W, et al. Age distribution and iron dependency of the T2 relaxation time in the globus pallidus and putamen. Neuroradiology 1993;35:119-24
35. Ge Y, Jensen J, Lu H, et al. Quantitative assessment of iron accumulation in the deep gray matter of multiple sclerosis by magnetic field correlation imaging. AJNR Am J Neuroradiol 2007;28:1639-44
36. Hu CJ, Jensen H, Williams K, et al. Comparison of susceptibilityweighted imaging and magnetic field correlation imaging. Proc Int Soc Mag Reson Med 2009;17:4524
37. Kovtunovych G, Eckhaus MA, Ghosh MC, et al. Dysfunction of the heme recycling system in heme oxygenase 1-deficient mice: effects on macrophage viability and tissue iron distribution. Blood 2010;116:6054-62
38. Arnsten AF, Rubia K. Neurobiological circuits regulating attention, cognitive control, motivation, and emotion: Disruptions in neurodevelopmental psychiatric disorders. J Am Acad Child Adolesc Psychiatry 2012;51:356-67
39. Cotton PL, Smith AT. Contralateral visual hemifield representations in the human pulvinar nucleus. J Neurophysiol 2007;98: 1600-09